throbber
ROITT’S .
`
`ESSENTIAL
`
`IMMUNOLOGY
`
`Ivan Roitt
`
`
`
`
`
`Lassen - Exhibit 1043, p. 1
`
`

`

`© 1971 , 1974, 1977, 1980,1984,1988,
`1991, 1994, 1997 by Blackwell Science Ltd
`Editorial Offices:
`Osney Mead, Oxford OX2 DEL
`25 John Street, London WC1N 28L
`23 Ainslie Place, Edinburgh E113 6A]
`350 Main Street, Malden
`MA 02148 5018, USA
`54 University Street, Carlton
`Victoria 3053, Australia
`
`Other Editorial Offices:
`
`Blackwell Wissenschafts-Verlag GmbI-l
`Kurfiirstendamm 57
`10707 Berlin, Germany
`Zehetnergasse 6
`A-1140 Wien
`Austria
`
`All rights reserved. No part of
`this publication may be reproduced,
`stored in a retrieval system, or
`transmitted, in any form or by any
`means, electronic, mechanical,
`photocopying, recording or otherwise,
`except as permitted by the UK
`Copyright, Designs and Patents Act
`1988, without the prior permission
`of the copyright owner.
`
`Set by Excel Typesetters Co., Hong Kong
`Printed and bound in Italy
`by Rotolito Lombarda 5.p,A., Milan
`
`The Blackwell Science logo is a
`trade mark of 81a ckwell Science Ltd,
`registered at the United Kingdom
`Trade Marks Registry
`
`First published 1971
`Reprinted 1972 (twice), 1973 (twice)
`Second edition 1974, Reprinted 1975
`Third edition 1977, Reprinted 1978, 1979
`Fourth edition 1980, Reprinted 1982, 1983
`Fifth edition 1984
`Sixth edition 1988, Reprinted 1988
`Reprinted with corrections 1989
`Seventh edition 1991
`Eighth edition 1994, Reprinted 1996
`Ninth edition 1997
`
`Spanish editions 1972, 1975, 1978, 1982,
`1988,1989,1993
`ltalian editions 1973, 1975, 1979,1986,
`1988, 1990, 1993, 1995
`Portuguese editions 1973, 1979,1983
`French editions 1975, 1979,1990
`Dutch editions 1975,1978, 1982
`Japanese editions 1976, 1978,1982,1986,1988
`German editions 1977, 1984, 1988, 1993
`Polish edition 1977
`Greek editions 1978,1989, 1992
`Turkish edition 1979
`Slovak edition 1981
`lndonesian editions 1985, 1991
`Russian edition 1988
`Korean edition 1991
`ELBS editions 1977, 1982,1988, Reprinted 1991
`Chinese (Taiwan) editions 1991, 1994
`
`DISTRIBUTORS
`Marston Book Services Ltd
`PO Box 269
`Abingdon
`Oxon OX14 4YN
`(Orr/are: Tel: 01235 465500
`Fax: 01235 465555)
`
`USA
`Blackwell Science, lnc.
`Commerce Place
`350 Main Street
`Malden, MA02148 5018
`(Orders: Tel: 800 759 6102
`617 388 8250
`Fax: 617 388 8255)
`
`Canada
`Copp Clark Professional
`200 Adelaide St West, 3rd Floor
`Toronto, Ontario MSH 1W7
`(Orders: Tel: 41 6 597-1616
`800 815-9417
`Fax: 416 597—1617)
`
`Australia
`Blackwell Science Pty Ltd
`54 University Street
`Carlton, Victoria 3053
`(Orders: Tel: 3 9347 0300
`Fax: 3 9347 5001)
`
`Catalogue records for this title
`are available from the British Library
`and the Library of Congress
`ISBN 0-86542—729-1
`
`Lassen — Exhibit 1043, p. 2
`
`Lassen - Exhibit 1043, p. 2
`
`

`

`_ C
`
`ONTENTS
`
`Target cells are told to commit suicide
`Ecslnophils
`SUM MARY
`
`2 - Specific acquired Immunity, 22
`THE NEED FOR SPECIFIC IMMUNE MECHANISMS
`ANTIBODY — THE SPECIFIC ADAPTOR
`Antibody initiates a new complement pathway (‘classical’) .....
`Complexed antibody activates phagocytlc cells ..........
`CELLULAR BASIS OF ANTI BODY PRODUCTION
`Antibodies are made by lymphocytes ...............
`Antigen selects the lymphocytes which make antibody
`The need for clonal expansion means humeral Immunity must
`be acquired
`ACCUIRED MEMORY
`Secondary antibody responses are better
`ACQUIRED IMMUNITY HAS ANTIGEN SPECIFICITY . ..
`Discrimination between different antigens
`Discrimination between self and noneeli
`VACCINATION DE PENDS 0N ACDUI RED MEMORY
`CELL-MEDIATED IM MUNITY PROTECTS AGAINST
`INTRACELLULAR ORGANISMS ...............
`Cytokine-produclng T—cells help macrophages to kill Intracellular
`parasites ............................
`Virally Infected cells can be killed by cytotoxic T-cells and
`ADCC
`IMMUNOPATHOLOGY .....................
`SUM MARY
`FURTHER READING ....................
`General re'adlng
`Reierence work
`.
`Historical
`In-depth series for the advanced reader .............
`Current Information .....................
`Multiple choice questions ...................
`Electronic publications (linked to ‘Roltt‘s Essential
`Immunology)
`Major journals ......................
`
`22
`22
`23
`25
`25
`25
`26
`
`26
`28
`28
`30
`30
`32
`32
`
`33
`
`33
`
`33
`35
`35
`37
`37
`37
`3B
`38
`38
`38
`
`39
`39
`
`xiv
`
`xix
`
`8 9
`
`10
`II
`11
`11
`11
`11
`12
`12
`12
`12
`14
`
`16
`16
`18
`18
`18
`
`PREFACE ..............
`
`ACKNOWLEDGEMENTS ...................
`
`ABBREVIATIONS ...........
`
`USER GUIDE ............... . .........
`
`PART 1
`
`- THE BASIS OF IMMUNOLOGY
`
`Innate immunity, 3
`-
`I
`EXTERNAL BARRIERS AGAINST INFECTION
`PHAGOCYTIC CELLS KILL MICROORGANISMS
`Poiymarphs and macrophages are dedicated ‘professional’
`phagocytes ..........................
`The poiymorphonuclear neutrcphll ...............
`The macrophage .......................
`Microbes are engulfed by phagocytosis ............ .
`.
`.
`There Is an array of killing mechanisms ..............
`Killing by reactive oxygen Intermediates ............
`Killing by reactive nitrogen intermediates ............
`Killing by preformed antlmlcroblals ...............
`......
`COMPLEMENT FACI LITATES PHAGOCYTOSIS
`Complement and Its activation ..................
`CB undergoes slow spontaneous cleavage ...........
`03b levels are normally tightly controlled ............
`03 convertase is stabilized on microbial surtaces ........
`The post-03 pathway generates a membrane attack complex
`.
`Complement has a range of defensive biological functions .....
`I 03b adheres to complement receptors ............
`2 Biologically active fragments are released ..........
`3 The terminal complex can induce membrane lesions
`COMPLEMENT CAN MEDIATE AN ACUTE
`INFLAMMATORY REACTION
`The most cell plays a central role .................
`Macrophages can also do it ...................
`HUMORAL MECHANISMS PROVIDE A SECOND
`DEFENSIVE STRATEGY ...................
`Acute phase proteins Increase In response to infection .
`.
`.
`.
`.
`.
`.
`lnterterons Inhibit viral replication ................
`EXTRACELLULAR KILLING .................
`Natural killer (NK) cells ....................
`
`Lassen — Exhibit 1043, p. 3
`
`Lassen - Exhibit 1043, p. 3
`
`

`

`VI
`
`CONTENTS
`
`PART 2
`
`THE RECOGNITION OF ANTIGEN
`
`Complement genes contribute to the remaining class III region
`ofthe MHC ..........
`
`3 - Antibodies, 43
`
`43
`
`.
`
`.
`
`THE BASIC sreucrune Is A FOUR-PEPTIDE UNIT .
`MIN ACID sequences REVEAL VARIATIONS IN
`IMMUNOGLOBULIN STRUCTURE .............. 45
`IMMUNOILOBULIN IENES ................. 45
`lmmunogloballns are encoded by multiple gens segments ..... 45
`A special mechanism effects VDJ recombination ......... 4B
`STRUCTURAL VARIANTS OF THE sAsIc
`IMMUNOGLOBULIN MOLECULE ,,,,,,,,,,,,,, 47
`lsotypes ............................ 47
`Allolypes ............................ 47
`ldlotypee ............................ 50
`IMMUNOGLOBULINS ARE FOLDED INTO GLOBULAR
`DOMAINS WHICH SUBSERVE DIFFERENT
`FU N CTIC N S .......................... 50
`lmmunoglcbulln domains have a characteristic structure ..... 50
`The variable domain binds antigen ................ 51
`Constant region domains determine secondary biological function .
`5T
`IMMUNOGLOBULIN CLASSES AND SUBCLASSES
`.
`.
`.
`51
`lmmunoglobulln G has major but varied roles in extracellular
`defenses ............................ 53
`Activation of the classical complement pathway ........ 53
`The diversity of FC'y receptors ................. 54
`Nonprecipltaling ‘univalent‘ antibodies ............. 57
`lmmunoglobulin A guards the mucosal surtaces ......... 57
`lmmunogiobuiln M provides a defense against bacteremla ..... 58
`Immunoglobulln D Is a cell surface receptor ,,,,,,,,,,,, 59
`Immunoglabulln E triggers inflammatory reactions ........ 59
`lmmunaglcbulins are further subdivided into subclasses
`.
`.
`.
`.
`.
`60
`SU MMARY .......................... 61
`FURTHER READING ..................... 92
`
`63
`
`.
`
`.
`
`.
`
`4 - Membrane receptors for antigen, 63
`THE B-CELL SURFACE RECEPTOR FOR ANTIGEN ,
`The B-cell inserts a Iransmembrane Immunoglobulln into
`Its surface ........................... 63
`The surface immunoglobulin ls complexes with associated
`membrane proteins ....................... 64
`THE T-CELL SURFACE RECEPTOR FOR ANTIGEN .
`.
`.
`.
`65
`The reaeptorfor antigen Is a trcnsmembrane heterodlmer .....
`65
`There are two classes of T-cell receptors ............. 65
`The encoding of T-oell receptors Is slmllarto that of
`66
`lmmunoglobullns ....................... .
`The CDS complex is an integral part of the T-cell receptor ...... 67
`THE GENERATION OF DIVERSITY FOR ANTIGEN
`RECOGNITION
`....................... 68
`Infrachaln amplification of diversity .............
`.
`.
`69
`Random VDJ combination Increases diversity geometrically .
`.
`.
`69
`Playing with the junctions .................. 89
`Interchain amplification ..................... 70
`Somatic hypermulatlon ..................... 70
`THE MAJOR HISTOCOMPATIBILITY COMPLEX
`(MHC) ............................ 71
`Glass | and class II molecules are membrane-bound
`heterodlmers .......................... 7i
`MHC class I ......................... 71
`MHC class It ......................... 71
`
`72
`.
`Gene map ofthe MHC ....................
`The genes at the MHC display remarkable polymorphism ..... 75
`Nomenclature ........................ 75
`Inheritance of the MHC ................... .
`77
`The tissue distribution of MHC molecules
`............ 77
`MHC Iuncflons ........................ 77
`SUMMARY .......................... 78
`FURTHER READING ....................
`79
`
`.
`.
`
`.
`.
`
`83
`83
`
`5 - The primary Interaction with antigen, 80
`WHAT Is AN ANTIGEN? ................... so
`Ofepitopes and antigen determinants .............. 81
`identification of B-cell epitopes ................. 81
`ANTIGENS AND ANTIBODIES INTERACT BY SPATIAL
`COMPLEMENTARITY NOT BY COVALENT BONDING .
`Variation In hapten structure shows importance of shape
`.
`.
`,
`Spatial complementarity of epitope and paratape can be
`demonstrated ........................ 83
`Antigen-antibody bonds are readily reversible .......... 84
`THE FORCES BINDING ANTIGEN TO ANTIBODY
`BECOME LARGE As INTERMOLECULAR DISTANCES
`BECOME SMALL ....................... 86
`i Electrostatic
`....................... 86
`2 Hydrogen bonding ..................... 87
`3 Hydrophobic
`....................... 87
`4 Van derWaals ...................... 87
`AFFINITY MEASURES STRENGTH 0F BINDING OF
`ANTIGEN AND ANTIBODY ................. 88
`The avidity of antiserum for antigen — the bonus effect
`of multivalency ........................ 88
`THE SPECIFICITY OF ANTIGEN RECOGNITION
`BY ANTIBODY IS NOT ABSOLUTE ............. 90
`WHAT THE T-CELL SEES .................. 9T
`Haploiype restriction revealsthe need forMHc participation
`.
`.
`.
`.
`91
`T-celis tecogntzea linear peptide sequence from the antigen .
`.
`.
`.
`91
`PROCESSING OF iNTRACELLULAR ANTIGEN
`FOR PRESENTATION BY CLASS I MHC
`......... 92
`PROCESSING OF ANTIGEN FOR CLASS II MHC
`93
`.
`.
`PRESENTATION FOLLOWS A DIFFERENT PATHWAY .
`THE NATURE OF THE ‘GROOVY’ PEPTIDE ........ 96
`Binding to MHC class I ..................... 96
`Binding to MHC class II ..................... 97
`THE up T-CELL RECEPTOR FORMS A TERNARY
`98
`.
`.
`.
`COMPLEX WITH MHC AND ANTIGENIC PEPTIDE .
`Topology of the ternary complex ................. 99
`T-CELLS WITH A DIFFERENT OUTLOOK ......... 99
`Non-classical class I molecules can also present antigen ...... 99
`MHC class I-llke molecules .................... 99
`The family of CDI non-MHC class l-like molecules can
`present exotic antigens ..................... 99
`yrs TCRs have some features 01' antibody ............. 100
`SUPERANTIGENS STIMULATE WHOLE FAMILIES
`OF LYMPHOCYTE RECEPTORS ............... IOO
`Bacterial toxins represent one major group of T-cell
`superontigens ......................... i 00
`Endogenous mouse mammary tumor viruses (MMTV) act
`as superantigens .................. I
`Microbes can also provide B-cellsuperantlgens
`.
`.
`.
`.
`
`.
`.
`
`.
`I
`
`.
`
`,
`.
`
`.
`.
`
`too
`IOI
`
`Lassen — Exhibit 1043, p. 4
`
`Lassen - Exhibit 1043, p. 4
`
`

`

`CONTENTS
`
`VI!
`
`THE RECOGNITION OF DIFFERENT FORMS OF ANTIGEN
`BY
`B- AND T-OELLS IS ADVANTAGEOUS TO THE
`HOST ............................. 101
`SUMMARY .......................... 102
`FURTHER READING ..................... 103
`
`TECHNOLOGY
`PART 3
`6 -
`lmmunochemlcaltechnlques, 107
`ESTIMATION OF ANTIBODY ................ 107
`,
`.
`.
`.
`Ancaggfggerggxlmgggzgz30:13:11,101;ch """" ’
`'
`'
`:2;
`.
`.
`_
`"""""
`The classical preolpltin reaction ................ 109
`Nonpreclpltating antibodies can be detected by nephelometry .
`. 109
`32:1:'21:;12:1de by nonpreclpltatlng antiboaiucan
`110
`""""""""""""
`fl:::;rr:3::ggflsm"°n ”V °°"”'e'°”"em
`1 10
`.
`Measurementofantibooyaftlnlty ............ .
`. 11o
`Agglutlnatlon ot antigen-cooled particles ............. 111
`“Effigy “"me ”5m” 3°"d'pmse ”"96" """" 11:
`Awtde variety oI labels is available .............. 113
`ELISA (enzyme-linked immunosorbent assay) """"
`113
`'
`'
`Other labels
`' 113
`Surface plasmon'resanan-ce """""""""""""" 1 1 4
`IDENTIFICATION AND MEASUREMENT or ANTIGEN.
`.
`. 114
`Precipitation reactianoan becarriedoutlngels
`......... 114
`mmmm‘o? °' “mans by°'°°"°ph°'es's and
`1 1 4
`.
`.'
`'
`'
`'
`.‘ """""""""
`1113::gxgngfigmz‘r‘ggiérzyu'mmusw”(SAND).
`:1:
`'_
`j
`:
`'
`'
`Sodium aoaecyl sultcte-polvccrytcmlde gel electrophoresis
`(SDS-PAGE) foranalysls 01 Immunoprecipitates and
`immunoblotting ........................ 1 18
`Thelmmunoassayotantlgens
`................. 117
`Immunoassay on multiple microspots
`............ 118
`Epilopemapplng ........................ 118
`T—aell epitopes ........................ 118
`B-aell epitopes ........................ 1 19
`DETECTION or IMMUNE cOMPLEX FORMATION .
`.
`.
`. 120
`figgggcmmlmfiewuggffl """""" 1::
`""""""""
`2:3":“11115 d: """""""""""" 1:?
`111mm maozoc‘iofjscan'be' ”10111; """""""" 123
`""""""""
`Engagflgamgzflf """"""""""" 1::
`Drugs can be based on the own;at mlnlboates ......... 125
`PURIFICATION OF ANTIGENS AND ANTIBODIES
`BY AFFINITY CHROMATOGRAPHY lllllllllll 126
`NEUTRALIZATIOII OF BIOLOGICAL ACTIVITY
`127
`'
`‘
`'
`'
`'
`To datect antibody
`' 127
`Using antibodyas anlnhlbllor ................. 127
`SU M MAIIY
`128
`"""""""""""""
`F
`URTHER READING ..................... 129
`
`7 - Cellulartechnlques, 130
`IS
`
`OLATION 0F LEUKOOYTE SUBPOPULATIONS ..... 130
`
`Bulktechnlquea ......................... 130
`Separation based on physical parameters ........... 130
`Separation exploiting biological parameters ........ .
`. 131
`Selection by antibody cooling ................. 131
`Cell selection bythe FACS .................... 131
`Enrichmentofantigen-specific populations .
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`. 131
`IMMUNOHISTOGHEMISTRY —LOGALIZATION
`OF ANTIGENS IN CELLS AND TISSUES
`......... 133
`lmmunofluotescence techniques ................ 133
`DirecI test with labeled antibody ............... 134
`.
`.
`Indirect test tarantlbody ................... 134
`High resolution with the confocal microscope
`.
`.
`.
`. ..... 135
`Flow oytotluorimetry ..................... 135
`.
`.
`.
`o1ng1gzgfisgznggrflmg rarecells """ ‘ """ :2;
`Locallzalionintissues ofagene ptoducl
`....... .
`.
`.
`.
`. 139
`ASSESSMENT OF FUNCTIONAL ACTIVITY .
`.
`.
`.
`.
`.
`.
`. 140
`The activity at phagocytic cells .................. 140
`gflrnggzpfijxgm """""""""" 1:3
`Enumefuflon of ammodv-1011111111; 66113"""""""" 14o
`The immunoiluoreseence sandwich test ............ 14o
`””9"” “"19““ '. """""" .‘
`.‘ """" 141
`Analysts offunclianalactivlly bvcellulorreconstltutlon ..... . 142
`Radiation chimeras ...................... 142
`Mice with severe combined Immunodeficiency (SCID) ...... I42
`P13:1?"1'151'12'11’;:°£1‘;::’n’;1‘1;z:1’es"""""""" ‘ 12:
`GENE‘TIG ENGINEERING OF'GIELLS""""""" 144
`insertion and moaltloation 01 genes in mammalian cells ...... 144
`Introducing newgenesintaanimals ............... 144
`Establishing ‘deslgnermice’ bearing newgenes ........ 144
`T'°$::'1'11‘:1':"°1‘:1"::;::: embw°"'° 5mm “”5 """" 1::
`SUMMARY W
`""""""""" 147
`""""""" " """"" '
`FURTHER READING """""""""" '
`‘48
`
`PART 4 ' THE ACQUIRED IMMUNE
`RE 5 P0 N S E
`
`8 - The anotomyotthe Immune response, 151
`THE SURFACE MARKERS or cats IN THE IMMUNE
`SYSTEM 151
`THE NEED FOR ORGANIZED LYMPHOID TISSUE ..... 151
`LYMPHOOYTES TRAFFIC BETWEEN LYMPHOID
`TISSUES
`153
`Lymphocytes home to their speeltlcllssues ............ 153
`“0:1?"If‘rgggllssglgsér‘rgmzz smges """"""" 1::
`p
`'
`""" ."""""" 4
`Step 2: p2 lntegrln activatIon and cellflattening
`........ 15
`Step 3:Transmlgrollon Into the tissue (dlapedesls) ....... 164
`Aeioserlookatthetnteracllngreceptorsandthelrligands ..... 156
`ENGAPSULATED "MPH MODES """"""" :52
`E-cell areas ........................... 1:7
`T-celloreas.......,....,..............
`SPLEEN IIIIIIIIIIIIIIIIIIIIIIII 158
`MUCOSAL-ASSOGIATED LYMPHOID TISSUE (MALT).
`.
`. 161
`Intestinal lymphocytes ..................... 162
`BONE MARROW CAN BE A MAJOR SITE OF ANTIBODY
`SYNTHESIS """"""""""""""""""""" 162
`
`Lassen — Exhibit 1043, p. 5
`
`Lassen - Exhibit 1043, p. 5
`
`

`

`VIII
`
`CONTENTS
`
`THE ENJOYMENT OF PRIVILEGED SITES ......... 163
`THE HANDLING OF ANTIGEN ............... 163
`Macrophages are general antigen-presenting cells ........ 163
`Interdlgitatlng dendritic cells presenlantigento T—Iymphacytes
`.
`.
`. 164
`Follicular dendritlc cells stimulate B-ceils in germinal centers
`.
`.
`. 165
`M-cells provide the gateway to the mucosal lymphoid system .
`.
`. 166
`SUMMARY ......................... 168
`FURTHER READING ...................
`167
`
`9 - Lymphocyte activation, 168
`IMMUNOCOMPETENT T- AND B-CELLS DIFFER IN
`MANY RESPECTS ....................... 168
`T-LYMPHOCYTES AND ANTIGEN-PRESENTING CELLS
`INTERACT THROUGH SEVERAL PAIRS OF ACCESSORY
`MOLECULES ......................... 169
`THE ACTIVATION 0F T-CELLS REQUIRES
`TWO SIGNALS
`....................... 169
`PROTEIN TYROSINE PHOSPHORYLATION IS AN EARLY
`EVENT IN T-CELL SIGNALING ............... 170
`DOWNSTREAM EVENTS FOLLOWING TCR
`SIGNALING ......................... 171
`The phosphatidylinosltol pathway ................ 171
`p21 rastunction ........................ 171
`Control of IL-2 gene transcription ................. 171
`Further thoughts on the control 01 T—cell triggering ......... 171
`A serial TOR engagement model tor T-cell activation
`...... 171
`Damping T-cell enthusiasm .................. 1 73
`B-CELLS RESPOND TO THREE DIFFERENT TYPES
`OF ANTIGEN ......................... 173
`I Typei thymus-independent antigens .............. I73
`2 Type 2 thymus-independent antigens ..... r ........ 173
`3Thymue-dependentantlgene ................. . 174
`The need tor collaboration with T—helper cells
`......... 174
`Antigen processing by B—celis ................ 174
`THE NATURE OF B-CELL ACTIVATION ........... 176
`B-celie are stimulated by cross-linking surface lg ......... 176
`T-heiper cells activate resting B—ceiis ............... 177
`SUMMARY .......................... 177
`FURTHER READING ...............
`.
`.
`.
`178
`
`10 - The production oteftectors. 179
`A SUGCESSION OF GENES ARE UPREGULATED
`BY T-CELL ACTIVATION .................. 179
`CYTOKINES ACT AS INTERCELLULAR MESSENGERS .
`. 179
`Cytokine action is transient and usually short range ........ 180
`Cytokines act through cell surface receptors ........... 180
`The gp 130 subfamily .................... 182
`The pc and ye receptor subfamilies .............. 182
`Signal transduction through cytoklne receptors .......... 182
`Cytokines often have multiple efteots ............... 182
`Network Interactions ...................... 1 83
`DIFFERENT CM T-CELL SUBSETS CAN MAKE
`DIFFERENT CYTOKINE PATTERNS ............. 184
`The bipolar THl/THZ concept ................... 184
`Interactions with cells of the innate Immune system may bias
`the THt/THZ response ...................... 185
`ACTIVATED T-CELLS PROLIFERATE IN RESPONSE
`TO CYTOKINES ....................... 186
`
`. 186
`T-CELL EFFECTORS IN CELL-MEDIATED IMMUNITY .
`Cytokines mediate chronic intiammatory responses ........ 186
`Early events ...................... .
`186
`Chemotaxls ........................
`187
`Macrophage activation .................... 1 S7
`Combating viral intectlon .................
`. 187
`Killer T~ceils .......................... 188
`The generation of cytotoxic T-celis ............ .
`. 188
`The lethal process ....................
`188
`inflammation must be regulated ................. 189
`PROLIFERATION AND MATURATION 0F B-CELL
`RESPONSES ARE MEDIATED BY CYTOKINES
`WHAT IS GOING ON IN THE GERMINAL CENTER?
`THE SYNTHESIS OF ANTIBODY
`IMMUNOGLOBULIN CLASS SWITCHING OCCURS
`IN INDIVIDUAL B-CELLS .................
`Class-switched B-ceils are subject to high mutation rates alter
`the initial response ....................... 193
`FACTORS AFFECTING ANTIBODY AFFINITY
`IN THE IMMUNE RESPONSE ................ 194
`The eftectot antigen dose ................. .
`194
`Maturation of affinity ................... .
`. 195
`MEMORY CELLS ....................... 195
`The memory population Is not simply an expansion of
`corresponding naive cells .................
`SUM MARY .......................
`FURTHER READING ..................
`
`.
`
`.
`
`. 190
`
`192
`
`196
`198
`199
`
`11 ' Controlmechanisms, 201
`. 201
`.
`.
`.
`.
`.
`ANTIGEN IS,A MAJOR FACTOR IN CONTROL
`Antigens can interfere with each other .............. 202
`ANTIBODY EXERTS FEEDBACK CONTROL ...... .
`202
`T-CELL REGULATION .................... 203
`T-helper cells ........ { ................. 203
`T-ceii suppression
`.
`Suppressor and helper epitopes can be discrete ........ 204
`Characteristics of suppression .............
`.
`. 204
`Suppression due to T-Tinteraction on antigen-presenting cells .
`. 206
`Ettector T-ceiis are guided to the appropriate target by MHC
`surface molecules .................... 207
`IDIDTYPE NETWORKS ................
`207
`James network hypothesis ................... 207
`Evidence for ldiotypic networks ................. 208
`Anti-Idiotype can be Induced by autoiagous ldiotypes ...... 208
`A network is evident in early life
`........... 208
`T-ceils can also do it ..................... 209
`Preoccupation ot networks with self ............... 209
`Idlotypic regulation of immune responses .
`,
`.
`......... 210
`Manipulation oi the immune response through ldiotypes ...... 21 1
`THE INFLUENCE OF GENETIC FACTORS ......... 213
`Some genes affect general responsiveness ........... . 213
`immune response linked to Immunoglobulln genes ........ 213
`Immune response can be Influenced by the MHC ......... 213
`The Ir genes map to the H-2| region and control T—B
`cooperation ......................... 214
`ARE THERE REGULATORY IMMUNONEUROENDOCRINE
`NETWORKS? ......................... 216
`A neuroendocrine feedback loop attesting immune responses
`.
`.
`. 216
`Sex hormones come into the picture ............... 217
`
`Lassen — Exhibit 1043, p. 6
`
`Lassen - Exhibit 1043, p. 6
`
`

`

`CONTENTS
`
`IX
`
`Inchlns towards ‘psycholmmunology' ------------ 2‘7
`EFFECTS OF DIET. EXERCISE. TRAUMA AND AGE
`0N IM MUN'TY
`------------------ -
`Malnutrition diminishes the effectiveness at the Immune
`response ____________________________ 218
`otherfactors ________________________ 219
`SUM MARY IIIIIIIIIIIIIIIIIIIIIIII 220
`wan-I ER READING ..................... 221
`
`- 21 3
`
`-
`
`12 ' Ontogeny and phylogeny, 223
`THE MULTIPOTENTIAL HEMATOPOIETIC STEM cELL
`GIVES RISE TO THE FORMED ELEMENTS
`on”; Hoop ,,,,,,,,,,,,,,,,,, 223
`THE THYMUS PROVIDES THE ENVIRONMENT
`FOR ME LL DIFFERENTIATION ........... 225
`Bone marrow stem cells become immunocompetent T-cells
`In the thymus ......................... 226
`1-0 ELL omoce My ,,,,,,,,,,,,,,,,, 227
`Differentiation is accompanied by changes In surface markers
`.
`.
`. 227
`Receptor rearrangement .................... 228
`The development ofoiB receptors ............... 229
`The development of ya receptors ,,,,,,,,,,,,,,, 229
`Cells are positively selected for self-MHc restriction In the thymus .
`. 229
`1.05“ TOLE RANGE __________________ 23]
`The induction of immunological tolerance is necessary to avoid
`self-reactivity ......................... 231
`Self-tolerance can be induced In the thymus ............ 231
`lntrathymlc clonal deletion leads to self-tolerance ......... 231
`Factors affecting positive or negaflve selection In the thymus .
`.
`. 233
`7.09" tolerance can be due to clonal energy ,,,,,,,,,, 234
`Infectious anergy ...................... 235
`Look of communication can cause unresponsiveness ....... 235
`s-cELLs DIFFERENTIATE IN THE FETAL LIVER
`AND THEN I" BONE MARROW lllllllllllll 236
`3.1 AND 3,2 CELLS REPRESENT TWO DISTINCT
`. 237
`popu LATI 0 N s lllllllllllllllll '
`DEVELOPMENT OF 3.95“ spEcmcn-y _________ 233
`The sequence of lmmunoglobulln gene rearrangements ...... 238
`The Importance of allelic excluslon """""""""""" 240
`Different specific responses can appear sequentially ....... 240
`THE INDUCTION 0F TOLERANCE IN
`s-meuocyres ,,,,,,,,,,,,,,,,,,,,,, 240
`Tolerance can be caused by clonal deletion and clonal anergy
`.
`.
`. 240
`Tolerance may result from helpless B—cells ____________ 241
`THE OVERALL RESPONSE IN THE NEONATE
`______ 243
`THE Evolu'nou OF THE IMMUNE RESPONSE IIIII 243
`Recoanltlon of self is fundamental for multicellular organisms
`.
`.
`. 243
`anertebrates have microbial defense mechanisms ....... 244
`Adaptive Immune responses appear with the vertebrates ..... . 245
`Lower vertebrates ...................... 245
`Mausuppea, llllllllllllllllllllllll 245
`Generation of antibody diversity ............... . 247
`THE EVOLUTION OF bIsTINcT e- ANb T-cELL
`Human WAS AGOOMPANIED at THE DEVELOPMENT
`OF SEPARATE sITEs FOR DIFFERENTIATION ...... 247
`CELLULAR necoeNITwN NOLEcIILEs ExPLOIT
`THE IMMUNOGLOBULI N eENE su PERFAMILY ...... 247
`SUM MARY ________________________ 248
`FURTHER READING ,,,,,,,,,,,,,,,,,,,,, 250
`
`PART 5 ~
`
`I M M U N ITY TO IN FE CTION
`
`13 - Adversarial strategies during infection, 253
`
`INFLAMNATION NEVIstrEo ................ 254
`Mediators of Inflammation
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.
`.- ........ 254
`Leukocytes bind to endothetlal cells through paired adhesion
`"'01900193 --------------------------- 255
`Initiation of the acute inflammatory response .......... . 255
`The ongoing inflammatory process ............... . 256
`Regulation and resolution of inflammation ............ 257
`°h'°n'°'""°mm°"°" --------------------- 258
`EXTRACELLULAR BACTERIA SUSCEPTIBLE To KILLING
`at PNAoochOSIs ANo cOMPLEMENT ......... 258
`Bacterial survival strategies ................... 258
`Emmi! PhagOchOSls -------------------- 258
`Challeng'W "'9 complement system -------------- 25'
`An'lflen'cvarlaflm ---------------------- 260
`The host counter-attack ..................... 26g
`TON” neutralization --------------- . ----- 25‘
`Opsonization 0' “9'3”” ------------------ - 261
`Some further effects of complement .............. 263
`The secretory immune system protects the external mucosal
`surfaces --------------------------- 253
`Some specific bacterial infections ................ . 265
`”37"" W" '0" GROW 'N A" '"TMGELL" UR
`HABIT“
`-
`_ -------------------- 2‘57
`Bacterial 90ml)“
`_
`j
`-
`- -------------- 267
`09‘9”“ '5 by T-cell-mediated Immunity (0M1) ----------- 263
`Activated macrophages klll Intracellular parasites ......... 268
`Examples of Intracellular bacterial Infections ........... 269
`”573”“ -------------------------- 259
`Tuberculosis ------------------------ 269
`“WOW IIIII .
`~
`,
`.
`.
`,
`-
`-
`-
`-
`3 ----------- 271
`IMMUNITY T0 VIRA INFECTION .
`.’ ........... 271
`lmmunltycan beevaded byantlgenchanges .......J.
`.
`.
`. 271
`Changing antigens by dim and Shift
`.~ ............. 271
`Mutation can produce antagonistic T-cell epltopes ....... 272
`50m“ “"1595 0°” ““991 0””99” Process” ----------- 272
`VIIuses can InIeneIe WIIh Immune eflecIor mwhunisms ...... 272
`Playing games with "‘9 complement WSW“ ---------- 272
`Sabotaging cell-mediated immunity .............. 272
`Protection by serum antibody .................. 273
`Local factors -------------------------- 273
`Cell-mediated immunity gets to the intracellular virus ....... 273
`NK cells can kill VitOllViflTecIed targets ............. 273
`'cytotoxlcT-cells (Tc) are cruclaielements In lmmunltyto
`infection bV budding viruses ----------------- 275
`Oyloklnes recruit effectors and provide a ‘oordon sanitalre’
`.
`I
`. 275
`”'1‘me has a part '00 ------------------- 275
`'M M" N I" To FUNGI
`' ------- , --------- 275
`IMMUNITY To PARASlTic INFEcTIONs ......... 276
`"'5 “05* "38an vvvv . ------------ -
`.
`-
`- 273
`HWOWIWWUHW
`--------------------- 277
`Cell-medlatefllmmunltv ---------------- .
`.
`-
`- 278
`mm “families t’Y ”'9 Parasite ---------------- 279
`WWW” BMW mechanisms -------------- 279
`AVO'd'W 0""99" recognlllon bV "'9 "03' ------------ 28°
`Deviation of the host immune response ............ 281
`lmmunopathology ----------------------- 251
`
`Lassen — Exhibit 1043, p. 7
`
`Lassen - Exhibit 1043, p. 7
`
`

`

`GONTE NTS
`
`SUMMARY .............. . ........... 2B]
`FURTFIER READING ..................... 284
`
`14 - Prophylaxis, 285
`PASSIVELY ACQUIRED IMMUNITY ............. 285
`Maternalty acquired antibody .................. 287
`Pooled human y-globulln .................... 287
`Cultured anttbodies made to order ................ 287
`Adoptive transfer of cytotoxic T—celis ............... 288
`VACCINATION ........................ 288
`Herd Immunity ......................... 288
`strategic considerations .................... 288
`KILLED ORGANISMS AS VACCINES ........... 288
`LIVE ATTENUATED ORGANISMS HAVE MANY
`ADVANTAGES As VACCINES ................ 289
`Classical methods of attenuation ................ 290
`Attenuation by recombinant DNA technology ........... . 290
`Microbial vectors for other genes ................. 290
`Constraints on the use at attenuated vaccines ........... 293
`SUBUNIT VACCINES CONTAINING INDIVIDUAL
`. 293
`PROTECTIVE ANTIGENS ................ .
`The use of purified components ................. 293
`Antigens can be synthesized through gene cloning ........ 294
`The naked gene itself acts as a vaccine .............. 295
`EPITOPE-SPECIFIC VACCINES MAY BE NEEDED.
`.
`.
`.
`. 296
`Epitopes can be mimicked by synthetic peptides ......... 297
`B-celt epitopes ........................ 297
`T—cell epitopes ........................ 297
`Making the peptides immunogenic ........ . ...... 298
`ldtotypes can be exploited as epitope-speolftc vaccines ...... 299
`Unwanted epltope-Ioss mutants can correctly told desired
`discontinuous B-celt epttopes .................. 299
`CURRENT VACCINES .................... 299
`EXPERIMENTAL VACCINES IN DEVELOPMENT ...... 300
`Malaria ........................... I
`. 300
`Schlstosomtasis .................... .
`.
`.
`.
`. 302
`Cholera ............................ 303
`Tuberculosis .......................... 303
`ADJ UVANTS ......................... 303
`Depot effects .......................... 303
`Macrophage activation ..................... 304
`Specific etfects on lymphocytes ................. 304
`NEW APPROACHES TO THE PRESENTATION
`OF ANTIG EN ......................... 304
`SUMMARY .......................... 305
`FURTHER READING ..................... 307
`
`PART 6
`
`CLINICAL IMMUNOLOGY
`
`Immunodeficiency. 31 I
`15 -
`PRIMARY IMMUNODEFICIENCY STATES
`IN THE HUMAN ....................... 311
`DEFICIENCIES OF INNATE IMMUNE MECHANISMS .
`.
`. 311
`Phagocytlc cell detects ..................... 311
`Complement system deficiencies ................. 312
`Defects In control proteins ................... 312
`Deficiency of components of the complement pathway ..... 313
`PRIMARY B-CELL DEFICIENCY .............. . 314
`
`PRIMARY T—CELL DEFICIENCY ............... 315
`COMBINED IMMUNODEFICIENCY ............ 317
`Mutation In the common oytokine receptory‘1 chain causes SCID .
`. 317
`9010 can be due to mutations In purine salvage
`pathwayenzymes ...................... , 317
`Other SCID variants ....................... 317
`RECOGNITION OF IMMUNODEFICIENCIES ........ 317
`SECONDARY IMMUNODEFICIENCY ............ 318
`ACGUIRED IMMUNODEFICIENCY SYNDROME (AIDS).
`. 319
`AIDS results from Infection by a human immunodeficiency virus
`(HIV) ............................. 319
`The infection of cells by HIV .................... 31
`The AIDS Infection depletes helper T-celts ............. 321
`Natural history of the disease ................. 321
`Mechanisms of depletion ................... 323
`Diagnosis of AIDS ....................... 324
`The control of AIDS ....................... 324
`Identifying protective Immune responses ............ 324
`The development of animal models .............. 325
`Othertherapeutlc strategies ............... t
`.
`. 325
`SU M MARY .......................... 326
`FURTHER READING .................... 327
`
`18 - Hypersensitivity, 328
`INAPPROPRIATE IMMUNE RESPONSES CAN LEAD
`TO TISSUE DAMAGE
`.
`.
`,
`. ................ 328
`TYPE I —ANAPHYLACTIC HYPERSENSITIVITY ...... 329
`The phenomenon of anaphylaxie ................. 329
`Human anophylactlc antibodies are mainly IgE .......... 330
`Anaphylaxis is triggered by clustering of IgE receptors on mast cells
`through cross—linking ...................... 330
`Atopic allergy ......................... . 331
`Clinical responses to Inhaled allergens ............. 331
`Food allergy ....... '. ................. 333
`Etlotagical factors In the development of atoplc allergy ..... 333
`Cltnlcat tests for allergy ,
`' ................... 334
`Therapy ........................... 334
`Allergen avoidance ..................... 334
`Modulation of the Immunological response ......... 335
`Most cell stabilization ................... 335
`Mediator antagonism .................... 337
`Attacking chronic infla

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket